Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis B Patients With HBeAg-positive”

Showing 5 of 0 results

Not applicableWithdrawnNCT00715715
What this trial is testing

Efficacy Study of Prednisone Priming to Treat Asian Chronic Hepatitis B Patients

Who this might be right for
Chronic Hepatitis B
Maimonides Medical Center
Post-approval studies (Phase 4)Study completedNCT00922207
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Adefovir or Entecavir in Patients With HBeAg-Positive Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 280
Post-approval studies (Phase 4)Active Not RecruitingNCT06743438
What this trial is testing

Long-term Safety and Efficacy of Tenofovir Amibufenamide in Patients With CHB

Who this might be right for
Hepatitis B, Chronic
Jiangsu Hansoh Pharmaceutical Co., Ltd. 640
Large-scale testing (Phase 3)Ended earlyNCT00376259
What this trial is testing

Study of Combination Therapy With LdT Plus Adefovir Versus Adefovir Alone

Who this might be right for
Hepatitis B
Novartis 43
Testing effectiveness (Phase 2)Study completedNCT04439539
What this trial is testing

JNJ-73763989, Pegylated Interferon Alpha-2a, Nucleos(t)Ide Analog (NA) With or Without JNJ-56136379 in Treatment-naive Participants With Hepatitis B e Antigen (HBeAg) Positive Chronic Hepatitis B Virus (HBV) Infection

Who this might be right for
Hepatitis B, Chronic
Janssen Research & Development, LLC 54

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation